Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Gastroenterology Clinics of North America|June 1, 1992
The role of the mucosal immune system in inflammatory bowel diseaseS Schreiber, A Raedler, W F Stenson, et al.Immunopharmacology|April 1, 1986
Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patientsR P MacDermott, M G Kane, L L Steele, et al.Immunopharmacology|April 1, 1986
Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processesF Shanahan, A Niederlehner, R P MacDermott, et al.Gastroenterology|February 1, 1989
Inhibition of antibody secretion by 5-aminosalicylic acidR P MacDermott, S R Schloemann, M J Bertovich, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
Aggregated bovine IgG inhibits mannose receptor expression of murine bone marrow-derived macrophages via activationS Schreiber, W F Stenson, R P MacDermott, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1991
Monomeric IgG2a promotes maturation of bone-marrow macrophages and expression of the mannose receptorS Schreiber, J S Blum, W F Stenson, et al.Journal of Gastroenterology|December 1, 1996
Alterations of the mucosal immune system in inflammatory bowel diseaseR P MacDermottThe Medical Clinics of North America|November 1, 1994
Alterations in the mucosal immune system in ulcerative colitis and Crohn's diseaseR P MacDermottCurrent Protocols in Immunology|April 25, 2008
Measurement of prostaglandins and other eicosanoidsW F StensonCurrent Opinion in Gastroenterology|October 13, 2006
Mechanisms of tissue protection and repair in inflammatory bowel diseaseW F StensonPageof 17